Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Karl G. Blume"'
Autor:
Karl G. Blume, E. Donnall Thomas
Publikováno v:
Thomas’ Hematopoietic Cell Transplantation
Autor:
Michael Gratwohl, Mahmoud Aljurf, Eliane Gluckman, Hildegard Greinix, José R. Nuñez, Marcelo C. Pasquini, Nicolas Novitzky, Mohamad Mohty, Helen Baldomero, Dennis L. Confer, Frederic R Appelbaum, Yoshiko Atsuta, Machteld Oudshoorn, Karl Frauendorfer, Yoshihisa Kodera, Alejandro Madrigal, Jon J. van Rood, Luis Fernando Bouzas, Luc Noel, Alois Gratwohl, Minako Iida, Jakob Passweg, Jeffrey H. Lipton, Dietger Niederwieser, Jeff Szer, Mary M. Horowitz, Karl G. Blume, Lydia Foeken
Publikováno v:
The Lancet Haematology. 2:e91-e100
Summary Background The transplantation of cells, tissues, and organs has been recognised by WHO as an important medical task for its member states; however, information about how to best organise transplantation is scarce. We aimed to document the ac
Autor:
Michael B. Maris, Benedetto Bruno, Peter A. McSweeney, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Karl G. Blume, Edward Agura, Amelia Langston, Lars Vindeløv, Ann E. Woolfrey, Mary E.D. Flowers, Rainer Storb, Firoozeh Sahebi, Finn Bo Petersen, Paul J. Martin, Boglarka Gyurkocza, Richard T. Maziarz, Parameswaran Hari, Dietger Niederwieser, Kai Hübel, Michael A. Pulsipher, Ginna G. Laport, Thomas R. Chauncey, Andrew M. Yeager, Mohamed L. Sorror, Marco Mielcarek, Georg-Nikolaus Franke, Wolfgang Bethge, H. Joachim Deeg, George E. Georges
Publikováno v:
Journal of Clinical Oncology. 31:1530-1538
Purpose We designed a minimal-intensity conditioning regimen for allogeneic hematopoietic cell transplantation (HCT) in patients with advanced hematologic malignancies unable to tolerate high-intensity regimens because of age, serious comorbidities,
Autor:
Frederick R. Appelbaum, Karl G. Blume, Robert S. Negrin, E. Donnall Thomas, Stephen J. Forman
Publikováno v:
Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation
Fully revised for the fifth edition, this outstanding reference on bone marrow transplantation is an essential, field-leading resource. * Extensive coverage of the field, from the scientific basis for stem-cell transplantation to the future direction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba0d3fd160bb1a533c493d77e5749335
https://doi.org/10.1002/9781118416426
https://doi.org/10.1002/9781118416426
Autor:
Judith A. Shizuru, Laura Johnston, Lisa Y. Law, Ruby M. Wong, Robert S. Negrin, Karl G. Blume, Ginna G. Laport, Robert Lowsky, Keith Stockerl-Goldstein, Sandra J. Horning
Publikováno v:
Biology of Blood and Marrow Transplantation. 12:703-711
Allogeneic hematopoietic cell transplantation (HCT) has been shown to be curative in a group of patients with aggressive non-Hodgkin lymphoma (NHL). A previous study has demonstrated equivalent outcomes with a conditioning regimen based on total body
Autor:
Edward Agura, Brenda M. Sandmaier, Barry E. Storer, Peter A. McSweeney, David G. Maloney, Richard T. Maziarz, Karl G. Blume, Rainer Storb, Michael B. Maris, Benedetto Bruno, Amelia Langston, Thomas R. Chauncey, Constanze Kliem, Michael A. Pulsipher, James C. Wade, Judith A. Shizuru
Publikováno v:
Biology of Blood and Marrow Transplantation. 12(4):454-465
We previously reported results in 71 patients with advanced hematologic malignancies given HLA-matched unrelated granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell (G-PBMC) grafts after fludarabine 90 mg/m2, 2 Gy of t
Autor:
Thomas R. Chauncey, David G. Maloney, Jerry P. Radich, Brenda M. Sandmaier, George E. Georges, Jan M. Zaucha, A. Woolfrey, Judith A. Shizuru, Peter A. McSweeney, Richard A. Nash, Dietger Niederwieser, Marie Térèse Little, Hans-Peter Kiem, Karl G. Blume, Christopher R. Flowers, Rainer Storb, Lyle Feinstein, Michael B. Maris
Publikováno v:
Annals of the New York Academy of Sciences. 938:328-339
Conventional allografting produces considerable regimen-related toxicities that generally limit this treatment to patients younger than 55 years and in otherwise good medical condition. T cell-mediated graft-versus-tumor (GVT) effects are known to pl
Autor:
H. Joachim Deeg, Barry E. Storer, Frederick R. Appelbaum, Michele E. Lloid, Stephen J. Forman, Laura Johnston, Karl G. Blume, Terry Furlong, Jeannine S. McCune, Richard A. Nash, Robert P. Witherspoon, Paul J. Martin, Mark M. Schubert, Hans-Peter Kiem, Claudio Anasetti, John T. Slattery, Pablo Parker, Rainer Storb
Publikováno v:
Biology of Blood and Marrow Transplantation. 11:495-505
In a phase I/II study, the combination of cyclosporine (CSP) and mycophenolate mofetil (MMF) was investigated as graft-versus-host disease (GVHD) prophylaxis after myeloablative conditioning and hematopoietic cell transplantation from an HLA-matched
Autor:
Monic J. Stuart, Christopher Bredeson, Karl G. Blume, Michael R. Loken, Michael A. Pulsipher, Jose F. Leis, Rainer Storb, Michael B. Maris, Benedetto Bruno, Mohamed L. Sorror, Barry E. Storer, Edward Agura, Jerald P. Radich, Brenda M. Sandmaier, Peter A. McSweeney, David G. Maloney, Thomas R. Chauncey, U Hegenbart, Amelia Langston, Haifa Kathrin Al-Ali
Publikováno v:
Journal of Clinical Oncology. 23:3819-3829
Purpose Patients with chemotherapy-refractory chronic lymphocytic leukemia (CLL) have a short life expectancy. The aim of this study was to analyze the outcome of patients with advanced CLL when treated with nonmyeloablative conditioning and hematopo
Autor:
Roy B. Jones, Charles Martinez, Keith Stockerl-Goldstein, J. L. Klein, James Murphy, Karl G. Blume, Yago Nieto, Roger Dansey, Steven G. Matthes
Publikováno v:
Biology of Blood and Marrow Transplantation. 10:276-282
We conducted a randomized, double blind, placebo-controlled multi-institutional trial to assess the ability of amifostine to protect patients against acute lung injury associated with cyclophosphamide/cisplatin/carmustine (BCNU) (STAMP I), a BCNU-con